SCHEMBL359232

SCHEMBL359232

CC(C)(C)C1=CC(=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)C=C(C(C)(C)C)C1=O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.52
MAPT P10636 3/20 0.52
ALDH1A1 P00352 2/20 0.52
MCL1 Q07820 1/20 0.52
CES2 O00748 1/20 0.52
PKM P14618 1/20 0.52
HPGD P15428 1/20 0.52
CES1 P23141 1/20 0.52
MPI P34949 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
GPR35 Q9HC97 1/20 0.38
POLB P06746 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14081321 0.89 ATM (0.48) ATMMAPTALDH1A1MCL1CES2
SCHEMBL442633 0.88 ATM (0.43) ATMMAPTALDH1A1MCL1CES2
SCHEMBL12852127 0.86 ATM (0.42) ATMMAPTALDH1A1MCL1CES2
SCHEMBL4751533 0.85 ATM (0.45) ATMMAPTALDH1A1MCL1CES2
SCHEMBL12677688 0.85 ATM (0.45) ATMMAPTALDH1A1MCL1CES2
SCHEMBL14673579 0.85 ATM (0.45) ATMMAPTALDH1A1MCL1CES2
SCHEMBL13929495 0.82 ATM (0.39) ATMMAPTALDH1A1MCL1CES2
SCHEMBL15759639 0.82 MAPT (0.50) ATMMAPTALDH1A1MCL1CES2
SCHEMBL853674 0.82 MAPT (0.52) ATMMAPTALDH1A1MCL1CES2
SCHEMBL15761111 0.81 ATM (0.38) ATMMAPTALDH1A1MCL1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174974-B Pyrano [3,2-b ] benzofuran-2-one framework compound and synthetic method and application thereof 新乡学院 2023-02-03 CN claimed
US-20060255322-A1 Methods and compositions for improved electrophoretic display performance WU ZARNG-ARH G 2006-11-16 US claimed
US-20040085619-A1 Novel Methods and compositions for improved electrophoretic display performance SIPIX IMAGING, INC. 2004-05-06 US claimed
US-12554207-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJIFILM BUSINESS INNOVATION CORP. (JP) 2026-02-17 US disclosed
WO-2025235307-A1 SOLVOLYSIS AND OXIDATION OF MIXED PLASTIC STREAMS ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2025-11-13 WO disclosed
US-20240384062-A1 IONOMER RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS KURARAY EUROPE GMBH (DE) 2024-11-21 US disclosed
EP-4397708-A1 IONOMER RESIN COMPOSITION, RESIN SHEET, AND LAMINATED GLASS Kuraray Europe GmbH (DE) 2024-07-10 EP disclosed
WO-2023190691-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE FORMATION DEVICE 三菱ケミカル株式会社 2023-10-05 WO disclosed
WO-2023190690-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, IMAGE FORMATION DEVICE, AND COMPOUND 三菱ケミカル株式会社 2023-10-05 WO disclosed
US-20230296995-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, ELECTROPHOTOGRAPHIC PHOTORECEPTOR CARTRIDGE, AND IMAGE FORMING DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2023-09-21 US disclosed
US-20230288847-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2023-09-14 US disclosed
US-20070023747-A1 Positive charging photoreceptor XEROX CORPORATION (US) 2007-02-01 US disclosed
US-7163771-B2 Imaging members XEROX CORPORATION (US) 2007-01-16 US disclosed
US-20060255322-A1 Methods and compositions for improved electrophoretic display performance WU ZARNG-ARH G 2006-11-16 US disclosed
US-20050007648-A1 Methods and compositions for improved electrophoretic display performance E INK CORPORATION 2005-01-13 US disclosed
US-20040085619-A1 Novel Methods and compositions for improved electrophoretic display performance SIPIX IMAGING, INC. 2004-05-06 US disclosed
EP-0641360-B1 PREPARATION OF ADDITION POLYMERIZATION CATALYSTS VIA LEWIS ACID MITIGATED METAL CENTER OXIDATION DOW CHEMICAL CO (US) 1997-10-01 EP disclosed
EP-0641360-A1 PREPARATION OF ADDITION POLYMERIZATION CATALYSTS VIA LEWIS ACID MITIGATED METAL CENTER OXIDATION. DOW CHEMICAL CO (US) 1995-03-08 EP disclosed
WO-1994021693-A1 PREPARATION OF ADDITION POLYMERIZATION CATALYSTS VIA LEWIS ACID MITIGATED METAL CENTER OXIDATION THE DOW CHEMICAL COMPANY (US) 1994-09-29 WO disclosed
US-5347024-A Preparation of addition polymerization catalysts via Lewis acid mitigated metal center oxidation THE DOW CHEMICAL COMPANY (US) 1994-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12554207-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus PDE6C, NR2E3, CRY1 ATM 2922/4885MAPT 885/4885ALDH1A1 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.